Literature DB >> 33557914

Adapting evidence-based clinical practice guidelines for people with attention deficit hyperactivity disorder in Saudi Arabia: process and outputs of a national initiative.

Fahad A Bashiri1,2, Turki H Albatti3,4,5, Muddathir H Hamad1, Haya F Al-Joudi6, Hadeel F Daghash7, Saleh M Al-Salehi8, Jeremy L Varnham9, Fatimah Alhaidar3, Omar Almodayfer10, Abdulkarim Alhossein11, Hesham Aldhalaan12, Yasser A Ad-Dab'bagh13,14, Nouf Al Backer15, Waleed Altwaijri10, Khalid Alburikan16, Maysaa W Buraik17, Mohammad Ghaziuddin18, Michael J Nester19, Hayfaa A Wahabi20, Samia Alhabib21, Amr A Jamal20,21,22,23, Yasser S Amer24,25,26,27.   

Abstract

BACKGROUND: We recently adapted the published National Institute for Health and Care Excellence (NICE) Attention deficit hyperactivity disorder (ADHD) diagnosis and management guideline to the Saudi Arabian context. It has been postulated that adaptation of evidence-based clinical practice guidelines to the local healthcare context rather than de-novo development will improve their adoption and implementation without imposing a significant burden on resources. The objective of this paper is to describe the adaptation process methodology utilized for the generation of the first national guideline for management of people with ADHD in Saudi Arabia.
METHODS: We used the KSU-Modified-ADAPTE methodology for the guideline adaptation process. We describe the full process in detail including the three phases of set-up, adaptation, and finalization. The process was conducted by a multidisciplinary guideline adaptation group in addition to an external review for the clinical content and methodology.
RESULTS: The group adapted ten main categories of recommendations from one source CPG (NICE). The recommendations include: (i) service organisation and training, (ii) recognition, identification and referral, (iii) diagnosis, (iv) support, (v) managing ADHD, (vi) dietary advice, (vii) medication, (viii) maintenance and monitoring, (ix) adherence to treatment, and (x) review of medication and discontinuation. Several implementation tools were compiled and developed to enhance implementability including a clinical algorithm, quality measures, coding system, medication tables, translations, patient information, and online resources.
CONCLUSIONS: The finalized clinical practice guideline provides healthcare providers with applicable evidence-based guidance for the management of people with ADHD in Saudi Arabia. The project also demonstrated the effectiveness of KSU-Modified-ADAPTE, and emphasized the value of a collaborative clinical and methodological expert group for adaptation of national guidelines.

Entities:  

Keywords:  ADHD; Adaptation; Attention deficit hyperactivity disorder; Eastern mediterranean region; Evidence-based medicine; Mental health; Practice guideline; Saudi Arabia

Year:  2021        PMID: 33557914     DOI: 10.1186/s13034-020-00351-5

Source DB:  PubMed          Journal:  Child Adolesc Psychiatry Ment Health        ISSN: 1753-2000            Impact factor:   3.033


  2 in total

1.  Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia.

Authors:  F A Al-Haidar
Journal:  East Mediterr Health J       Date:  2003 Sep-Nov       Impact factor: 1.628

2.  Knowledge, attitude, and performance of primary healthcare physicians in Aseer Region, Saudi Arabia about attention deficit hyperactivity disorder.

Authors:  Ayedh A Al-Ahmari; Rishi K Bharti; Mohammad S Al-Shahrani; Muffarah H Alharthi; Hassan M Alqarni; Hassan M Alshehri
Journal:  J Family Community Med       Date:  2018 Sep-Dec
  2 in total
  1 in total

Review 1.  Current Pharmacological Treatments for ADHD.

Authors:  Madeleine J Groom; Samuele Cortese
Journal:  Curr Top Behav Neurosci       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.